Rebecca A Garlena Selected Research

Nontuberculous Mycobacterium Infections

1/2021	Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains.
1/2021	Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.
1/2019	Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca A Garlena Research Topics

Disease

5	Infections 01/2021 - 06/2014
3	Nontuberculous Mycobacterium Infections 01/2021 - 01/2019
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2019
1	Virus Diseases (Viral Diseases) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Extensively Drug-Resistant Tuberculosis 01/2021
1	Cadaver (Cadavers) 10/2015

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
1	Therapeutic UsesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	PolyketidesIBA 01/2021
1	DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA 01/2019
1	Guanosine PentaphosphateIBA 01/2017
1	Ligases (Synthetase)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2014

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2021
1	Lung Transplantation 01/2019